UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer

Journal of cancer research and clinical oncology, 2023-11, Vol.149 (15), p.14035-14043

2023

Volltextzugriff (PDF)

Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC

Frontiers in immunology, 2022-06, Vol.13, p.858212-858212

2022

Volltextzugriff (PDF)

Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib

Clinical lung cancer, 2019-01, Vol.20 (1), p.59-62

2019

Volltextzugriff (PDF)

Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting

Pathology oncology research, 2024-03, Vol.30, p.1611590-1611590

2024

Volltextzugriff (PDF)

An integrated molecular risk score early in life for subsequent childhood asthma risk

Clinical and experimental allergy, 2024-05, Vol.54 (5), p.314-328

2024

Volltextzugriff (PDF)

EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin

Journal of cellular biochemistry, 2010-09, Vol.111 (1), p.207-217

2010

Volltextzugriff (PDF)

Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy

Theranostics, 2020, Vol.10 (2), p.856-866

2020

Volltextzugriff (PDF)

Gene Mutation Mapping in a Fatal Case of Phacomatosis Pigmentokeratotica Happle

Acta dermato-venereologica, 2020-08, Vol.100 (15), p.adv00241-adv00241

2020

Volltextzugriff (PDF)

Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

Targeted oncology, 2023-03, Vol.18 (2), p.257-267

2023

Volltextzugriff (PDF)

Regulation of p130Cas/BCAR1 Expression in Tamoxifen-Sensitive and Tamoxifen-Resistant Breast Cancer Cells by EGR1 and NAB21

Neoplasia (New York, N.Y.), 2012-02, Vol.14 (2), p.108-120

2012

Volltextzugriff (PDF)

Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2

Neoplasia (New York, N.Y.), 2012-02, Vol.14 (2), p.108-120

2012

Volltextzugriff (PDF)

Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer

Cellular and molecular gastroenterology and hepatology, 2022-01, Vol.13 (2), p.517-540

2022

Volltextzugriff (PDF)

Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities

The Journal of biological chemistry, 2015-05, Vol.290 (19), p.12247-12255

2015

Volltextzugriff (PDF)

Consensus molecular subtypes and RAS status as biomarker of treatment intensity with fluoropyrimidine, bevacizumab, and irinotecan in metastatic colorectal cancer (XELAVIRI, AIO KRK 0110)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.3552-3552

2021

Volltextzugriff (PDF)

POLE gene hotspot mutations in advanced pancreatic cancer

Journal of cancer research and clinical oncology, 2018-11, Vol.144 (11), p.2161-2166

2018

Volltextzugriff (PDF)

Reply: Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy

Journal of the American College of Cardiology, 2017-09, Vol.70 (13), p.1687-1687

2017

Volltextzugriff (PDF)

Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3)

The Journal of biological chemistry, 2015-10, Vol.290 (42), p.25275-25292

2015

Volltextzugriff (PDF)

Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity

The journal of pathology. Clinical research, 2021-01, Vol.7 (1), p.75-85

2021

Volltextzugriff (PDF)

Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer

Journal of personalized medicine, 2021-08, Vol.11 (9), p.835

2021

Volltextzugriff (PDF)

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer

The journal of pathology. Clinical research, 2023-01, Vol.9 (1), p.73-85

2023

Volltextzugriff (PDF)

Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level

JAAD international, 2024-06, Vol.15, p.157-164

2024

Volltextzugriff (PDF)

Influence of mRNA expression of fibroblast growth factor 2 ( FGF2 ) in colorectal cancer (CRC) cell lines and in patients with metastatic colorectal cancer (mCRC) treated with FUFIRI or mIrOx (FIRE1)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.3570-3570

2016

Volltextzugriff (PDF)

A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo

Tumor biology, 2016-08, Vol.37 (8), p.10665-10673

2016

Volltextzugriff (PDF)

A clinically applicable gene expression–based score predicts resistance to induction treatment in acute myeloid leukemia

Blood advances, 2021-11, Vol.5 (22), p.4752-4761

2021

Volltextzugriff (PDF)

26 – 50 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(51)
Buchkapitel
(1)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

NTRK fusion events and targeted treatment of advanced radioiodine refractory thyroid cancer

Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC

Successful Treatment of a Patient With NSCLC Harboring an EGFR Mutation and a Concomitant Met Exon 14 Skipping Mutation Combining Afatinib and Crizotinib

Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting

An integrated molecular risk score early in life for subsequent childhood asthma risk

EGR1, EGR2, and EGR3 activate the expression of their coregulator NAB2 establishing a negative feedback loop in cells of neuroectodermal and epithelial origin

Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy

Gene Mutation Mapping in a Fatal Case of Phacomatosis Pigmentokeratotica Happle

Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board

Regulation of p130Cas/BCAR1 Expression in Tamoxifen-Sensitive and Tamoxifen-Resistant Breast Cancer Cells by EGR1 and NAB21

Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2

Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer

Identification of Novel Crk-associated Substrate (p130Cas) Variants with Functionally Distinct Focal Adhesion Kinase Binding Activities

Consensus molecular subtypes and RAS status as biomarker of treatment intensity with fluoropyrimidine, bevacizumab, and irinotecan in metastatic colorectal cancer (XELAVIRI, AIO KRK 0110)

POLE gene hotspot mutations in advanced pancreatic cancer

Reply: Histopathological and Immunological Characteristics of Tachycardia-Induced Cardiomyopathy

Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3)

Mixed large cell neuroendocrine carcinoma and squamous cell carcinoma of the colon: detailed molecular characterisation of two cases indicates a distinct colorectal cancer entity

Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer

Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression level

Influence of mRNA expression of fibroblast growth factor 2 ( FGF2 ) in colorectal cancer (CRC) cell lines and in patients with metastatic colorectal cancer (mCRC) treated with FUFIRI or mIrOx (FIRE1)

A truncated phosphorylated p130Cas substrate domain is sufficient to drive breast cancer growth and metastasis formation in vivo

Checkpoint inhibitor–induced lichen planus differs from spontaneous lichen planus on the clinical, histological, and gene expression levelCapsule Summary

A clinically applicable gene expression–based score predicts resistance to induction treatment in acute myeloid leukemia

Suchergebnisse filtern